» Articles » PMID: 37646216

Global Burden of Atrial Fibrillation and Flutter by National Income: Results From the Global Burden of Disease 2019 Database

Overview
Date 2023 Aug 30
PMID 37646216
Authors
Affiliations
Soon will be listed here.
Abstract

Background Atrial fibrillation (AF) and atrial flutter (AFL) are common conditions that can lead to significant morbidity and death. We aimed to understand the distribution and disparities of the global burden of AF/AFL as well as the underlying risk factors. Methods and Results Data on the AF/AFL burden from the Global Burden of Disease data set were analyzed for the years 1990 to 2019, with countries grouped into low, lower-middle, upper-middle, and high national income classes according to World Bank categories. Data were supplemented with World Health Organization and World Bank information. The prevalence of AF/AFL has more than doubled (+120.7%) since 1990 in all income groups, though with a larger increment in middle-income countries (+146.6% in lower-middle- and +145.2% in upper-middle-income countries). In absolute numbers, 63.4% of AF/AFL cases originate from upper-middle-income countries, although the relative prevalence is highest in high-income countries. Prevalence of AF/AFL appears to be correlated with medical doctor rate and life expectancy. The most relevant AF/AFL risk factors are unevenly distributed among income classes, with elevated blood pressure as the only risk factor that becomes less common with increasing income. The development of these risk factors differed over time. Conclusions The global burden of AF/AFL is increasing in all income groups and is more pronounced in middle-income countries, with further growth to be expected. Underdiagnosis of AF/AFL in low- and middle-income countries may contribute to lower reported prevalence. The risk factor distribution varies between income groups.

Citing Articles

Temporal trends in the utilization, costs, and outcomes of concomitant left atrial appendage closure across a statewide collaborative.

Sanaiha Y, Kiaii B, Sun J, Madani M, Nguyen T, Shemin R JTCVS Open. 2025; 23:176-189.

PMID: 40061534 PMC: 11883682. DOI: 10.1016/j.xjon.2024.10.030.


The evolving epidemiological landscape of atrial fibrillation: trends, challenges, and opportunities for improved patient care.

Zuin M, Bertini M, Boriani G Europace. 2025; 27(2).

PMID: 40036692 PMC: 11879045. DOI: 10.1093/europace/euaf026.


Left atrial appendage velocity, association with inflammatory indices in non-valvular atrial fibrillation patients.

Khesali H, Ghaffari Jolfayi A, Soheili A, Rezapour P, Adimi S, Alirezaei T Future Cardiol. 2025; 21(2):103-111.

PMID: 39874020 PMC: 11812346. DOI: 10.1080/14796678.2025.2458414.


Demographic trends in mortality with older population due to atrial fibrillation and flutter from 1999-2020.

Sukaina M, Waheed M, Rehman S, Hasibuzzaman M, Meghani R World J Cardiol. 2025; 17(1):99933.

PMID: 39866211 PMC: 11755128. DOI: 10.4330/wjc.v17.i1.99933.


Clinical Efficacy and Safety of Ibutilide in Cardioversion of Atrial Fibrillation or Flutter in Indian Patients: A Multicenter Study.

Dewan B, Navale S, Shinde S, Chaudhary J Indian J Crit Care Med. 2025; 29(1):45-51.

PMID: 39802251 PMC: 11719548. DOI: 10.5005/jp-journals-10071-24885.


References
1.
Wang L, Ze F, Li J, Mi L, Han B, Niu H . Trends of global burden of atrial fibrillation/flutter from Global Burden of Disease Study 2017. Heart. 2020; 107(11):881-887. DOI: 10.1136/heartjnl-2020-317656. View

2.
Martin L, Tan T, Horn J, Bixler E, Kauffman G, Becker D . Comparison of the costs associated with medical and surgical treatment of obesity. Surgery. 1995; 118(4):599-606; discussion 606-7. DOI: 10.1016/s0039-6060(05)80024-8. View

3.
Chao T, Liu C, Tuan T, Chen S, Wang K, Lin Y . Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: Which scoring system should be used for Asians?. Heart Rhythm. 2015; 13(1):46-53. DOI: 10.1016/j.hrthm.2015.08.017. View

4.
Millenaar D, Fehlmann T, Scholz S, Pavlicek V, Flohr A, Dillmann M . Research in Atrial Fibrillation: A Scientometric Analysis Using the Novel Web Application SciPE. JACC Clin Electrophysiol. 2020; 6(8):1008-1018. DOI: 10.1016/j.jacep.2020.05.010. View

5.
Burdett P, Lip G . Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs. Eur Heart J Qual Care Clin Outcomes. 2020; 8(2):187-194. DOI: 10.1093/ehjqcco/qcaa093. View